$BLUS, $CRI, $CTSH, $CFX, $ECL
Below is a list of Wall Street’s Top analysts outlook for Key issues for Friday, as follows:
Bluebird Bio Inc. (NASDAQ:BLUE) has seen mixed results after earnings. BMO Capital Markets maintained its Outperform rating and raised its target price to 222 from 215. Cantor Fitz reiterated its Underweight rating.
Carter’s Inc. (NYSE:CRI) was reiterated as Outperform and the price target was raised to 135 from 125 at Oppenheimer.
Cognizant Technology Solutions Corp. (NASDAQ:CTSH) was raised to Buy from Hold with a 100 price target at Argus.
Colfax Corp. (NYSE:CFX) was reiterated as Buy with a 40 price target at Argus, with the independent research shop saying that the recent weakness offers a buying opportunity.
Ecolab Inc. (NYSE:ECL) was reiterated as Buy with a 150 price target at Argus, which noted that solid earnings and a raised dividend should help rectify its under-performance as a stock over the past quarter.
Have a terrific weekend.
Latest posts by Paul Ebeling (see all)
- Saudi Aramco Now the Most Valuable Public Company - December 11, 2019
- FMOC: Interest Rates Unchanged, Forecasts Show No Change in 2020 - December 11, 2019
- Two Key Stock Analyst’s Special Research Reports - December 11, 2019